MMCM
ZBH icon

Murphy & Mullick Capital Management’s Zimmer Biomet ZBH Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.3K Sell
596
-316
-35% -$27.7K 0.03% 291
2026
Q1 		$82.5K Hold
912
– – 0.06% 219
2025
Q4 		$82K Sell
912
-430
-32% -$40.8K 0.06% 217
2025
Q3 		$132K Hold
1,342
– – 0.1% 173
2025
Q2 		$123K Hold
1,342
– – 0.1% 166
2025
Q1 		$152K Hold
1,342
– – 0.15% 143
2024
Q4 		$142K Buy
+1,342
New +$144K 0.13% 149

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Murphy & Mullick Capital Management's ZBH Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its Zimmer Biomet (ZBH) stake by 35% in Q2 2026, selling an estimated $27.7K and leaving 596 shares worth $51.3K. The position accounts for 0.03% of the portfolio, ranked #291.

Murphy & Mullick Capital Management first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $152K in Q1 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Murphy & Mullick Capital Management held 596 shares of Zimmer Biomet worth $51.3K as of Q2 2026.
  • Murphy & Mullick Capital Management sold 316 Zimmer Biomet shares in Q2 2026, an estimated $27.7K.
  • Zimmer Biomet made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #291 holding.
  • Murphy & Mullick Capital Management first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's Zimmer Biomet position peaked at $152K in Q1 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.